ACS Chemical Biology
Articles
(15) Verez-Bencomo, V., Fernandez-Santana, V., Hardy, E., Toledo,
M. E., Rodrıguez, M. C., Heynngnezz, L., Rodriguez, A., Baly, A.,
Herrera, L., Izquierdo, M., Villar, A., Valdes, Y., Cosme, K.., Deler, M.
L., Montane, M., Garcia, E., Ramos, A., Aguilar, A., Medina, E.,
Torano, G., Sosa, I., Hernandez, I., Martınez, R., Muzachio, A.,
Carmenates, A., Costa, L., Cardoso, F., Campa, C., Diaz, M., and Roy,
R. (2004) A synthetic conjugate polysaccharide vaccine against
Haemophilus influenzae type b. Science 305, 522−525.
(16) Morelli, L., Poletti, L., and Lay, L. (2011) Carbohydrates and
immunology: synthetic oligosaccharide antigens for vaccine formula-
tion. Eur. J. Org. Chem., 5723−5777.
(17) Safari, D., Dekker, H. A. T., Joosten, J. A. F., Michalik, D.,
Carvalho de Souza, A., Adamo, R., Lahmann, M., Sundgren, A.,
Oscarson, S., Kamerling, J. P., and Snippe, H. (2008) Identification of
the smallest structure capable of evoking opsonophagocytic antibodies
against Streptococcus pneumoniae Type 14. Infect. Immun. 76 (10),
4615−4623.
(18) Nikolaev, A. V., Botvinko, I. V., and Ross, A. J. (2007) Natural
phosphoglycans containing glycosyl phosphate units: structural
diversity and chemical synthesis. Carbohydr. Res. 342, 297−344.
(19) Anderson, P. W., Pichichero, M. E., Stein, E. C., Porcelli, S.,
Betts, R. F., Connuck, D. M., Korones, D., Insel, R. A., Zahradnik, J.
M., and Eby, R. (1989) Effect of oligosaccharide chain length, exposed
terminal group, and hapten loading on the antibody response of
human adults and infants to vaccines consisting of Haemophilus
influenzae type b capsular antigen uniterminally coupled to the
diphteriae protein CRM197. J. Immunol. 142 (7), 2464−2468.
(20) Danieli, E., Lay, L., Proietti, D., Berti, F., Costantino, P., and
Adamo, R. (2011) First synthesis of C. difficile PS-II Cell wall
polysaccharide repeating unit. Org. Lett. 13 (3), 378−381.
(31) O’Hagan, D. T., Rappuoli, R., De Gregorio, E., Tsai, T., and Del
Giudice, G. (2011) MF59 adjuvant: the best insurance against
influenza strain diversity. Expert Rev. Vaccines 10 (4), 447−462.
(32) van den Brand, J. M. A., Kreijtz, J. H. C. M., Bodewes, R.,
Stittelaar, K. J., van Amerongen, G., Kuiken, T., Simon, J., Fouchier, R.
A. M., Del Giudice, G., Rappuoli, R., Rimmelzwaan, G. F., and
Osterhaus, A. D. M. E. (2011) Efficacy of vaccination with different
combinations of MF59-adjuvanted and nonadjuvanted seasonal and
pandemic influenza vaccines against pandemic H1N1 (2009) influenza
virus infection in ferrets. J. Virol. 85 (6), 2851−2858.
(33) Sebaihia, M., Wrem, B. W., Mullany, P., Fairwheather, N. F.,
Minton, N., Stabler, R., Thomson, N. R., Roberts, A. P., Cerdeno-
̃
́
Tarraga, A. M., Wang, H., Holden, M. T., Wright, A., Churcher, C.,
Quail, M. A., Baker, S., Bason, N., Brooks, K., Chillingtworth, T.,
Cronini, A., Davis, P., Dowd, L., Fraser, A., Feltwel, T., Hance, Z.,
Holroyd, S., KìJagels, K., Moule, S., Mungall, K., Price, C.,
Rabbinowitsch, E., Sharp, S., Simmonds, M., Steven, K., Unwin, L.,
Whithead, S., Dupuy, B., Dougan, G., Barrell, B., and Parkhill, J.
(2006) The multidrug-resistant human pathogen Clostridium difficile
has a highly mobile, mosaic genome. Nat. Genet. 38 (7), 779−786.
(34) He, M., Sebaihia, M., Lawley, T. D., Stabler, R. A., Dawson, L.
F., Martin, M. J., Holt, K. E., Seth-Smith, H. M., Quail, M. A., Rance,
R., Brooks, K., Churcher, C., Harris, D., Bentley, S. D., Burrows, C.,
Clark, L., Corton, C., Murray, V., Rose, G., Thurston, S., van Tonder,
A., Walker, D., Wren, B. W., Dougan, G., and Parkhill, J. (2010)
Evolutionary dynamics of Clostridium difficile over short and long time
scales. Proc. Natl. Acad. Sci. U.S.A. 107 (6), 7527−7532.
(35) Forgetta, V., Oughton, M. T., Marquis, P., Brukner, I.,
Blanchette, R., Haub, K., Magrini, V., Gerding, D. L., Loo, V. G.,
Mile, M. A., Mulvey, M. R., Rupnik, M., Dascal, A., and Dewar, K.
(2011) Fourteen-genome comparison identifies DNA markers for
severe-disease-associated strains of Clostridium difficile. J. Clin.
Microbiol. 49 (6), 2230−2238.
(21) Adamo, R., Tontini, M., Brogioni, G., Romano, M. R.,
Costantini, G., Danieli, E., Proietti, D., Berti, F., and Costantino, P.
(2011) Synthesis of laminarin fragments and evaluation of a β-(1,3)
glucan hexasaccaride-CRM197 conjugate as vaccine candidate against
Candida albicans. J. Carbohydr. Chem. 30, 249−280.
(22) Giannini, G., and Rappuoli, R. (1984) The amino acid sequence
of the two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
.
Nucleic Acids Res. 25 (12), 4063−4069.
(23) Oberli, M. A., Hecht, M.-L., Bindschadler, P., Adibekian, A.,
Adam, T., and Seeberger, P. H. (2011) A possible oligosaccharide-
conjugate vaccine candidate for Clostridium difficile is antigenic and
immunogenic. Chem. Biol. 18, 580−588.
(24) Preliminary results on immunogenicity of PSII-CRM197 and
HexaP-CRM197 were presented by Danieli, E., Tontini, M., Romano,
M. R., Berti, F., Costantino, P., and Adamo, R. at 16th Eurocarb, 3−7
July 2011, Sorrento (Italy).
(25) Mori, M., Ito, Y., and Ogawa, T. (1989) A highly stereoselective
and practical synthesis of cyclomannohexaose, cyclo (→4)-[α-D-Man]
5- α-D-Man-(1→). Carbohydr. Res. 192, 131−146.
(26) Higashi, K., and Susaki, H. (1992) A novel glycosydation
promoted by trimethylsilyl halide and zinc triflate. Chem. Pharm. Bull.
40, 2019−2022.
́ ́
(27) Chenede, A., Perrin, E., Rekaï, E. D., and Sinay, P. (1994)
̈
Synthesis of C-disaccharides by a samaium diiodie induced intra-
molecular coupling reaction. Synlett, 420−422.
(28) Mandal, M., Dukdin, V. Y., Geng, X., and Danishefsky, S. J.
(2004) In pursuit of carbohydrate-based HIV vaccines, part 1: the total
synthesis of hybrid-type gp120 fragments. Angew. Chem., Int. Ed. 43,
2557−2561.
(29) Lefeber, D. J., Kamerling, J. P., and Vliegenthart, J. F. G. (2001)
Synthesis of Streptococcus pneumoniae type 3 neoglycoproteins varying
in oligosaccharide chain length, loading and carrier protein. Chem.
Eur. J. 7 (20), 4411−4421.
(30) Galli, G., Medini, D., Borgogni, E., Zedda, L., Bardelli, M.,
Malzone, C., Nuti, S., Tavarini, S., Sammicheli, C., Hilbert, A. K.,
Brauer, V., Banzhoff, A., Rappuoli, R., Del Giudice, G., and Castellino,
F. (2009) Adjuvanted H5N1 vaccine induces early CD4+ T cell
response that predicts long-term persistence of protective antibody
levels. Proc. Natl. Acad. Sci. U.S.A. 106, 3877−3882.
1428
dx.doi.org/10.1021/cb300221f | ACS Chem. Biol. 2012, 7, 1420−1428